0001209191-18-014730.txt : 20180228 0001209191-18-014730.hdr.sgml : 20180228 20180228195646 ACCESSION NUMBER: 0001209191-18-014730 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180226 FILED AS OF DATE: 20180228 DATE AS OF CHANGE: 20180228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krognes Steve E. CENTRAL INDEX KEY: 0001666236 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38311 FILM NUMBER: 18654067 MAIL ADDRESS: STREET 1: 863 MITTEN ROAD, SUITE 102 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Denali Therapeutics Inc. CENTRAL INDEX KEY: 0001714899 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463872213 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 151 OYSTER POINT BLVD. STREET 2: 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 866-8548 MAIL ADDRESS: STREET 1: 151 OYSTER POINT BLVD. STREET 2: 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-26 0 0001714899 Denali Therapeutics Inc. DNLI 0001666236 Krognes Steve E. C/O DENALI THERAPEUTICS INC. 151 OYSTER POINT BOULEVARD, SECOND FLOOR SOUTH SAN FRANCISCO CA 94080 0 1 0 0 CFO and Treasurer Stock Option (right to buy) 22.16 2018-02-26 4 A 0 180000 0.00 A 2028-02-25 Common Stock 180000 180000 D 25% of the shares subject to the option will vest on February 26, 2019 and an additional 1/48 of the shares vest monthly thereafter. /s/ Tyler Nielsen, by power of attorney 2018-02-28